post check
automot industri
memori monthli price declin
full comment requir non-u analyst conflict disclosur
pleas click link
upgrad outperform
upgrad outperform
claridhi get win ad solid tumor tibsovo potenti
ndr highlight solid leas progress potenti pickup invest trend
asco abstract analysi complic limit data expect
nerlynx nala profil beat expect clinic meaning key
dupix ad reign see challeng throne
report better expect result
solid improv initi gain momentum
analyst day takeaway upbeat present lt target reiter mani initi
place support comp momentum/profit growth
recap model updat
introduc monthli analysi floor plan across new market
channel check privat off-sit investor call thought volatil
continu lead market growth show strongest gain
profit micron
cn benefit potenti princ rupert capac increas carload
price prior day market close estimate unless otherwis note
wa crude rail legisl updat
 of daili summari
state internet privaci
find research
insight www rbcinsightresearch com global research destin web contact capit market sale
repres access global research site
credit trend remain solid loan balanc continu modestli expand
valu usd unless otherwis note
valu usd unless otherwis note
upgrad outperform
upgrad outperform rais price
analysi point sequenti improv kbh price dynam
show better breadth base floor plan price increas diminish level
price reduct plan spec inventori alongsid earli sign
recoveri key market pt base tbv
upgrad outperform sector perform upgrad
outperform rais price analysi point
sequenti improv kbh price dynam show better breadth
base floor plan price increas diminish level price reduct
base floor plan spec inventori alongsid earli sign recoveri
key market expect could better support margin
coupl view see posit inflect order
gener peer group lead organ order growth support double-
digit commun count growth make current valuat attract entri
point stock trade tbv despit solid ytd ralli
expect gap smid-cap builder like larger cap builder
narrow pt base tbv
upgrad outperform
upgrad outperform sector perform increas
price base better stabil less preval price
reduct give us comfort compani abil hit fy gm guidanc
pt base tbv
upgrad outperform sector perform upgrad
outperform sector perform rais price
shown rel less breadth price power analysi
base floor plan rais price april vs aggreg peer
group also shown better stabil less preval price reduct
base plan spec saw price reduct vs group average
april give us comfort compani abil hit fy gm guidanc
mid-high rang rbce expect order growth
acceler start lap easier comp benefit avhi
addit also come bargain basement valuat
tbv make attract entri point view expect gap
smid-cap larger cap builder narrow pt base
tbv
valu usd unless otherwis note
valu usd unless otherwis note
claridhi get win ad solid tumor tibsovo potenti
tibsovo success claridhi trial cholangiocarcinoma de-risk
indic ad valuat importantli claridhi success remov
seen high-risk clinic overhang stock think set
stock well upsid mtap data importantli
mitapivat data see underappreci potenti
tibsovo see success solid tumor anticip claridhi
success today post-market close announc posit outcom
claridhi trial tibsovo idhmut cholangiocarcinoma trial perceiv
riski ahead today readout given aggress difficult-to-treat
natur cholangiocarcinoma anticip de-risk
indic link clariti claridhi appropri low expect
upsid real trial achiev primari endpoint demonstr
improv progression-fre surviv vs placebo control
releas note tibsovo safeti profil in-lin prior data plan
submit snda tibsovo cholangiocarcinoma potenti
market look forward full data present european
societi medic oncolog congress esmo sept better assess
durat respons increas probabl success
result new price target model
averag durat therapi look forward present
esmo gain granular durabl largest predictor valu
set model
ndr highlight solid leas progress potenti pickup invest
remain encourag abil lease-up sever avail block space
drive elev ffo growth estim current impli earn
growth increas compound-annual-growth-rate addit share
still trade discount in-plac estim maintain
rate increas target
estim stabil torrey point develop torrey plaza
redevelop project project gener
share increment ffo
make solid stride leasing-up first oregon squar project plan
second oregon squar build obtain larg contigu block
one beach estim deliveri lease-up three site add
annual ffo roll on-line
activ scour market bid acquisit
target invest mainli focus offic build value-
add re-posit opportun compani also interest multifamili
pro-forma net debt ebitda ratio stand long-
term target believ compani well posit improv
leverag level leasing-up avail block space
maintain report company-defin ffo
estim share respect introduc
estim
valu usd unless otherwis note
valu usd unless otherwis note
in-lin result though outflow higher expect fund flow sharpli
improv april/may pend usaa transact synergi target increas
realiz time-frame acceler growth remain near-term
revis ani per share estim
includ tax benefit revis factor
updat guidanc pend usaa transact assum juli close take
earn contribut termin harvest transact updat
fund flow aum estim pt adjust
factor upwardli revis group multipl
vctr report ani per share includ tax benefit line
estim consensu ex tax benefit ani per share
vs estim
sharpli improv fund flow trend post outflow
higher expect manag indic flow date sharpli
improv specif april fund in-flow may like
posit fund in-flow greater far
improv across compani distribut channel april/may good
portion came fund mandat previous
asco abstract analysi complic limit data expect
today market close abstract confer releas
preliminari data abstract first dose cohort
kra inhibitor disclos respons record
initi respons evalu patient orr respons report
data cutoff though respons evalu patient updat
orr come well sens st expect orr in-lin
tki respons rate achiev platinum chemo combo
abstract mellema et al meki chemo combo swog
trial abstract kra nsclc howev caution data
highli preliminari like repres initi lower-dos treat patient
would respons evalu first anticip orr dramat
improv higher dose patient respons evalu
view weak abstract potenti buy opportun
confer addit look detail surround
competit landscap kra target agent specif detail
mirati develop abstract trial
design data
valu usd unless otherwis note
valu usd unless otherwis note
nerlynx nala profil beat expect clinic meaning key
today market close abstract confer releas
nerlynx safety/efficaci profil nala trial
metastat breast cancer mbc appear better expect first glanc
nerlynx xeloda simpress diseas benefit vs tykerb xeloda
vs competit dataset rate gi-tox histor nerlynx
trial compel initi anticip howev caveat
nala util imodium loperamid prophylaxi nerlyx xeloda
arm tykerb xeloda arm could complic discuss
comparison vs histor dataset diarrhea nala
imodium vs control imodium vs extenet without
imodium given treatment decis late-lin set often govern
palli vs cur intent expect clinic risk/reward whether
magnitud benefit clinic meaning focu
dupix ad reign see challeng throne
jade trial read favor next-gener jaki
atop dermat morn announc success result first
trial oral inhibitor abrocitinib moder
sever atop dermat ad patient age first trial
read abrocitinib jade atop dermat efficaci safeti
program intend support registr file atopid dermat
detail press releas scant trial achiev co-primari studi
endpoint investig global assess iga improv point
clear almost clear proport patient achiev least
chang baselin eczema area sever index
safeti remain paramount concern jaki class follow cv concern
xeljanz lly/inci olumi rheumatoid arthriti though
first look safeti data next gener abrocitinib
trial ad appear clean abrocitinib saw low discontinu rate
across dose vs placebo discontinu
rate come slightli discontinu rate seen dupix
ad trial though caveat placebo arm solo trial also saw
report better expect result
view could see posit reaction trq share result
better forecast higher product sale
chang guidanc although focu remain mine plan review
trq reiter definit review estim perform
rio tinto expect complet end trq also note
engag mine manag rio tinto incorpor new geotechn data
mine design expect provid updat mid-year result
look detail updat entail confer call
financi result estim trq report ebitda
estim consensu ep estim
consensu stronger result due higher copper gold
sale volum lower oper cost period
copper sale mostli line gold well forecast trq report stronger
expect gold sale volum higher grade solid copper sale
volum quarter oper cost forecast help
stronger by-product credit trq expect gold product lower
rest year mine lower grade line guid product
valu usd unless otherwis note
market data usd financi data cni
march baba number came gener strong rel street expect
revenu well ahead key commerc segment tho tad
segment profit came street revenu guidanc
rmb impli least growth maintain outperform pt
number fundament trend strong w/ key growth metric
acceler vs dec revenu guid impli revenu decel
model acceler ebitda growth
vs y/i
y/i notabl acceler decemb quarter custom
manag revenu grew acceler prior quarter
estim slightli chang pt remain rmb
adjust ebitda rmb baba aggress invest
tier citi pt stay base blend average
sale adj ebitda estimate revenu compound-annual-growth-rate ebitda
compound-annual-growth-rate
maintain outperform ye macro continu remain overhang
still view baba fundament risk/reward compel china
commerc comp eas year includ new retail recent invest
remain robust potenti expand ebita growth near term
investor gain confid improv profit growth alibaba core-
core marketplac ebita continu invest expand strateg
valu usd unless otherwis note
valu usd unless otherwis note
cisco report solid quarter guid highlight growth
infrastructur platform y/i growth secur notabl compani
state data center busi also y/i help quell fear
take-away cisco report solid quarter across board guidanc
also better expect concern spend slowdown
impress follow growth infrastructur platform data
center y/i gross margin expand q/q secur growth
came suggest share gain catalyst seri continu
grow estim doubl digit appear gain posit
custom traction put item togeth along limit inorgan
revenu contribut growth think organ trend solid
defus bear belief surround near-term revenu declin final one
item view neg servic provid side appear
see notabl spend paus net net saw hole print
believ long-term thesi remain intact potenti earn
bull case reiter outperform
solid improv initi gain momentum
post strong start year result comfort ahead
expect compani continu gain momentum oper
improv portfolio optim support favor occup
trend benign reimburs backdrop
take-away genesi continu gain momentum improv effort
post anoth quarter solid result improv oper
trend earn growth execut manag portfolio optim
strategi achiev same-stor occup growth second consecut
quarter same-stor ebitdar growth third consecut quarter
impress improv primarili reflect
stabl censu follow divestiture/closur non-cor under-perform
asset improv cost manag benign reimburs environ
continu withhold guidanc manag expect posit
censu trend solid ancillari perform continu year
support favor reimburs backdrop optim pdpm
manag contend posit patient provid
initi place support comp momentum/profit growth
continu one favorit stock given view compani
multipl identifi top-lin driver potenti gener upward
sales/earn revis today compani reiter lt financi target
comp sale growth ebit margin ldd ep
valu usd unless otherwis note
valu usd unless otherwis note
growth detail oper improvements/strateg initi
place/underway remain buyer
addit reiter lt financi target tractor underlin multipl
initi place/underway drive top line growth profit
improv continu highlight ticket growth support
sell initi price optim tool defer financ
primari driver comp upsid past quarter expect factor
along roll-out new assort plan tool improv in-
stock reduc markdown risk stockyard kiosk store year-end
mitig impact tough comparison ahead invest spend
plateau enabl oper leverag comp forecast
msd sale compani privat label credit card
gener sale lift first year use number
store visit tractor defer financ program launch
march drive increas big-ticket sale card
ride lawn mower sale card increas
given histor experi consumer-rel defer financ
program lengthi runway penetr rate increas tractor estim
grow percentag sale card current
next year believ tractor defer financ program
could sizabl growth driver least next month
recap model updat
zayo reach agreement acquir privat equiti consortium
cash transact expect close much valu
stock realiz pt
zayo reach agreement acquir privat equiti consortium
transact subject sharehold regulatori approv
target close financi result better
expect revenu vs rbc/consensu
signific out-performance fiber solut off-set modest
under-perform transport zcolo adjust ebitda
vs support top-lin beat equat
margin line expect revenu
ebitda estim previou
previou respect much valu
stock realiz pt offer price
provid takeaway compani coverag asco
abstract releas tonight
includ data mru capmatinib
attend may expect gather addit detail
meet help clarifi opportun asset
valu usd unless otherwis note
valu usd unless otherwis note
introduc monthli analysi floor plan across new
collabor element collect detail hyperloc data floor
plan home list largest home builder
track trend across commun base floor plan
spec list monthli basi believ scale depth
data well abil track like-for-lik list price provid uniqu
insight new hous market builder-specif trend
data matter could fall short believ
data provid extrem use insight monthli like-for-lik price
trend serv direct reflect demand well provid
insight potenti margin trend also believ squar footag trend
use current environ shift underway toward
price dynam improv increment posit builder saw
like-for-lik sequenti price increas base floor plan april
throughout time saw base floor plan
sequenti price reduct fall april feb/march view
trend encourag creat upsid potenti margin est
combin better recent order trend increment posit
group view rel risk/reward smid-cap attract
upgrad outperform increas price target across
group
attend asco annual meet may chicago
review abstract select impact and/or
interest poster present confer inclus
planner also summar key present day front
host kol dinner sunday june ct focu
car-t/cel therapi well genitourinary/precis oncolog
gener pharma sector takeaway post check
channel check privat off-sit investor call thought volatil
return gener corpor off-sit spent last
day speak industri contact execut investor recent price
opioid headlin well fundament sector sinc
valu usd unless otherwis note
valu usd unless otherwis note
valu cad unless otherwis note
valu usd unless otherwis note
pre-myl result continu see support stabil
improv eros trend greater expect ebitda
step-down back-end weight year mani case left
understand trepid around outlook bigger challeng equiti
perform come step-down brought left us higher
leverag exhibit two unknown cash call opioid liabil price
fix alleg like settleabl year resolut
remain neg headlin near-term rel make case
sustain equiti upsid near-term drawn de-lev timelin
lack near-term catalyst back-end weight year perpetu
neg headlin ok trial start make difficult despit stabilizing/
improv trend may understand limit investor interest
sector would argu ev/ebitda valuat reflect
draconian scenario like realiz
earn compani within coverag
univers seen neg ebitda revis
highlight canadian automot industri
pleasur host annual confer toronto may
key execut airline/aerospac automot engin
 construct industri product transport wast manag
sector present analyst-moder session note
summar key invest theme came confer togeth
thorough review key highlight company-by-compani
continu lead market growth show strongest gain
cmss latest medicar advantag part enrol data show
mco continu gain market share sequenti
growth outpac provid overal membership increas
sequenti may member mco gain
group rest industri uptick show
strongest sequenti membership growth may
member show strongest sequenti gain
absolut number basi gain gain
recent acquir aetna platform gain
member sinc april carrier
see slight membership declin fewer member sequenti
valu usd unless otherwis note
valu cad unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
overal medicar part membership declin slightli sequenti
total live membership across downtick
well continu lead industri pdp member
sinc april follow pdp member
respect sequenti may ci reflect express
script pdp membership remain essenti flat sequenti
member far smallest pdp popul member
sequenti
memori monthli price declin nand product number
profit micron
take-away saw notabl inflect base new data provid last
night first found nand product number declin total
wafer start q/q y/i decemb march dram product
remain elev view think nand bottom dram wafer
start flattish q/q micron show impress profit
highest nand oper margin dram margin also surpass sk
hynix think bullet three import stock perspect
suggest micron multipl improv maintain profit
current cycl final look group think
expect remain mute think fundament improv
time frame view prior month neg stock like
trade in-lin us/china trade commentari net net impress
micron oper margin secondli remain confid
memori space whole admit us china relat could materi
impact invest thesi
cn benefit potenti princ rupert capac increas carload
summar week carload data well outlin capac expans plan
princ rupert
intern of daili
genel energi genl chairman announc departur valeura energi
state internet privaci regul crypto
earn larg rear-view mirror turn focu three
import internet topic privaci regul crypto brief
note share high-level thought implic could
sector fast approach elect season beyond
explain think privaci issu continu grow big internet
compani regul may strengthen domin thought
implement crypto could potenti repres solut
issu perhap existenti risk
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
comment highlight within recent releas us retail open-end fund
data strateg insight simfund month april
us retail industri fund flow april retail fund flow ex etf index fund
soften us equiti annual organ declin month
intern equiti annual organ declin month
growth month
estim chang revenu trend analysi retail asset mix composit
estim annual fee revenu suggest manag fee revenu trend
increas m/m averag april coverag group tradit
asset manag attribut increas revenu growth strong m/
equiti market return month break specif estim
annual revenu trend compani exhibit view varianc
chang estim revenu chang stock price could
driven factor outsid market perform aum thu could
basi investig
report increas total north dakota oil ga product
march march total product oil product
mb/d may eia dpr show march oil
mb/d mb/d natur ga product increas bcf/
produc well heat map show
product concentr total mckenzi mountrail
dunn counti north dakota second-largest oil-produc state
account total us oil volum
wa crude rail legisl updat
impact recent wa crude-by-rail legisl last week governor
washington sign new legisl requir tighter control crude-by-rail
shipment sb legisl goe effect januari
prohibit crude-by-rail shipment unless oil vapor pressur psi
howev new standard becom effect refin increas
rail import baselin level net
effect less sever origin anticip still result hard cap
state crude-by-rail import independ refin anacort
tacoma ferndal refineri washington reli
crude rail extent
credit trend remain solid loan balanc continu modestli expand
april trust manag card data summari top six card issuer
trust averag basi averag april charge-off increas slightli
march decreas bp year ago period meanwhil
averag day delinqu came prior
month rel stabl year ago gener charge-off
delinqu rel consist support favor view
manag basi four name coverag univers
produc averag charge-off modestli higher
march year ago meanwhil averag day delinqu
declin modestli march season
consist prior year though year-over-year basi delinqu
increas bp continu observ modestli rise credit loss
delinqu across major name continu view trend
accept reflect gener portfolio season term loan
balanc trend growth gener modest highlight solid
growth discov prior month
capit market busi name use certain branch subsidiari royal bank canada includ dominion secur inc
capit market llc europ limit royal bank canada hong kong branch royal bank canada sydney branch inform contain
report compil capit market sourc believ reliabl represent warranti express impli made royal
canada capit market affili person accuraci complet correct opinion estim contain
report constitut capit market judgement date report subject chang without notic provid good faith without
legal respons noth report constitut legal account tax advic individu tailor invest advic materi prepar gener
circul client prepar without regard individu financi circumst object person receiv invest
servic contain report may suitabl recommend consult independ invest advisor doubt
suitabl invest servic report offer sell solicit offer buy secur past perform guid
futur perform futur return guarante loss origin capit may occur capit market research analyst compens base
part overal profit capit market includ profit attribut invest bank revenu everi provinc canada state
 countri throughout world law regul type secur invest product may offer
resid well process result secur discuss report may elig sale jurisdict
capit market may restrict publish research report time time due regulatori restrict and/ intern complianc polici
case latest publish research report avail client may reflect recent materi chang applic industri and/or applic subject
compani capit market research report current date set forth research report report circumst
constru solicit act secur broker dealer jurisdict person compani legal permit carri
busi secur broker dealer jurisdict full extent permit law neither capit market affili
person accept liabil whatsoev direct consequenti loss aris use report inform contain herein matter
contain document may reproduc copi mean without prior consent capit market
addit inform avail request
public approv capit market llc member finra nyse sipc regist broker-deal accept
respons report dissemin unit state recipi report regist broker-deal bank act
broker dealer capac wish inform regard effect transact secur discuss report
contact place order capit market llc
public approv dominion secur inc member iiroc canadian recipi report design institut
ontario accredit investor british columbia alberta sophist purchas quebec similar permit purchas provinc
wish inform regard effect transact secur discuss report contact place order
dominion secur inc without way limit forego accept respons report dissemin canada
public approv europ limit el author prudenti regul author regul
conduct author fca prudenti regul author connect distribut unit kingdom materi gener
distribut unit kingdom retail client defin rule fca rbcel accept respons report dissemin
unit kingdom
materi distribut germani europ limit frankfurt branch regul bundesanstalt fr finanzdienstleistungsaufsicht bafin
receiv advic australia
materi distribut australia royal bank canada sydney branch abn afsl materi prepar
gener circul take account object financi situat need recipi accordingli recipi act
materi consid appropri materi regard object financi situat need materi relat acquisit
possibl acquisit particular financi product recipi australia obtain relev disclosur document prepar respect product
